Advisory Committee on Immunization Practices: Meeting

---
identifier: "/us/fr/E7-11789"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Advisory Committee on Immunization Practices: Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "E7-11789"
section_name: "Advisory Committee on Immunization Practices: Meeting"
positive_law: false
currency: "2007-06-19"
last_updated: "2007-06-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E7-11789"
document_type: "notice"
publication_date: "2007-06-19"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "72 FR 33760"
fr_volume: 72
---


#  Advisory Committee on Immunization Practices: Meeting

*Correction:* This notice was published in the *Federal Register* on May 4, 2007, Volume 72, Number 86, page 25318. The matters to be discussed have been changed.

*Matters To Be Discussed:* The agenda will include discussions on Vaccine Financing; Hepatitis A Post-Exposure Prophylaxis which will include a VFC Vote; Cold Adapted Influenza Vaccine; Immunization Safety; Tdap-IPV-Hib Combination Vaccine (Pentacel); MCV4 Dose to 2 years; Vaccine Shortages; Economic Analyses of Vaccines; Evidence-Based Recommendations; Human Papillomavirus Vaccine; Update on HIV Vaccines; Childhood Immunization Schedule; Adult Immunization Schedule; Update on Pneumococcal Vaccines Working Group; Update on Vaccines during Pregnancy and Breastfeeding Working Group; Hepatitis B update on Adult Recommendations; and Agency updates. VFC Votes will be taken to add Pentacel to the Diphtheria, Tetanus, Pertussis Resolution; to the Haemophilus Influenza Type B Resolution and to the Polio Resolution pending the Food and Drug Administration approval for licensure of Pentacel. Amended to include a VFC Vote on FluMist.

Agenda items are subject to change as priorities dictate.

*Contact Person for More Information:* Demetria Gardner, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., (E-05), Atlanta, Georgia 30333, telephone 404/639-8836, fax 404/639-6258.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR.

Dated: June 12, 2007.

Elaine L. Baker,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.